News

Conducting Investigations and Discovery in China, Part II: Navigating Judicial and Regulator Expectations in Cross-Border Reviews
In this second part, we delve into strategies for effectively reviewing information under restricted conditions for ...
Medscape7d
Angiotensin II-Receptor Antagonists: An Overview - Medscape
Angiotensin II-receptor antagonists are well tolerated and are as effective as ACE inhibitors in decreasing blood pressure. Introduction. High blood pressure affects over 50 million Americans, but ...
Medscape7d
Angiotensin II-Receptor Antagonists: An Overview - Page 13 - Medscape
Losartan is metabolized by the CYP isoenzyme system; however, the effects of potent inhibitors of CYP3A4 and CYP2C9 on losartan pharmacokinetics have not been clinically studied.
ahajournals.org18d
A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With ... - AHA/ASA Journals
Abstract The efficacy and safety of various doses of losartan potassium, a specific and selective angiotensin II receptor antagonist, were compared with those of placebo and enalapril maleate 20 mg in ...
ahajournals.org27d
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction | Circulation - AHA/ASA Journals
In the PARAGON-HF trial (Prospective Comparison of ARNI With ARB Global Outcomes in Heart Failure With Preserved Ejection Fraction), the effects of sacubitril-valsartan were compared with those of ...